Close Menu

NEW YORK – Roche announced Tuesday that its Cobas HPV test for human papillomavirus was approved by the US Food and Drug Administration for use with its high-throughput Cobas 6800/8800 systems.

The Cobas HPV test was previously approved for use with the Cobas 4800 system in 2014. It detects the presence of the DNA of HPV genotypes 16 and 18 in cervical samples, which are responsible for 70 percent of all cervical cancers, according to Roche. It also reports the 12 other high-risk HPV types as a combined result from one sample.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.